MedPath

Study evaluating Front-line health care workers serial blood COVID-19 antibody results in relation to symptom presentatio

Not Applicable
Withdrawn
Conditions
Coronavirus Disease 19 (COVID-19)
SARS-CoV-2
Infection - Other infectious diseases
Public Health - Other public health
Respiratory - Other respiratory disorders / diseases
Registration Number
ACTRN12620000493943
Lead Sponsor
Albury Wodonga Health
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Withdrawn
Sex
All
Target Recruitment
50
Inclusion Criteria

• Participants aged 18 years or over
• Participants who are front-line health care workers that may have cared for SARS-CoV-2 positive patients and/or been involved in testing suspected SARS-CoV-2 patients and/or work in a high-risk setting. High-risk setting is defined as the Emergency Department, Intensive Care, Medical wards caring for patients with COVID-19 or dialysis unit
• Participants must be accessible for follow up testing
• Able to read, write and understand English Participant Information and Consent Form
• Signed Participant Information and Consent Form

Exclusion Criteria

• Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol
• Research study personnel as identified in this Protocol

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the rate of front-line healthcare workers at Albury Wodonga Health who demonstrate SARS-CoV-2 antibody seroconversion [Monthly for six months following enrollment or until presentation of Coronavirus symptoms]
Secondary Outcome Measures
NameTimeMethod
To determine workplace environment exposure risk assessed by study-specific questionnaire and contact tracing.[Monthly for six months following enrollment or until presentation of Coronavirus symptoms];To determine rate and range of symptoms expressed by front-line healthcare workers assessed by study-specific questionnaire[Monthly for six months following enrollment or until presentation of Coronavirus symptoms]
© Copyright 2025. All Rights Reserved by MedPath